Support from readers like you keeps The Journal open.
You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.
If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.
BRITISH DRUG MAKER GlaxoSmithKline is to to seek regulatory approval for the world’s first ever vaccine against malaria.
GSK hope to get the green light for the prototype vaccine after trials showed it offered children a partial shield against the disease.
Results for the latest trial stage of the closely-followed RTS,S vaccine were unveiled at a conference in Durban, South Africa which gathered experts on malaria in Africa.
It showed that 18 months after vaccination, children aged five to 17 months had a 46 per cent reduction in the risk of clinical malaria compared to unvaccinated peers.
But in infants aged six to 12 weeks at the time of vaccination, efficacy was lower: a 27 per cent reduction in risk.
A spokeswoman for GSK told AFP that the company would file an application to the European Medicines Agency (EMA) under a process aimed at facilitating new drugs for poorer countries.
Under that process, the European medications watchdog gives a “scientific opinion” on the safety and efficacy of the vaccine.
This opens the way for the vaccine to be considered by the World Health Organisation (WHO), which in turn can fast-track its licensing in individual countries in Africa.
“We will submit, in 2014, an application for a scientific opinion by the Committee for Medicinal Products for Human Use on RTS,S through the EMA Article 58 procedure,” the GSK spokeswoman said.
“The intent is not to make the vaccine available in the EU as it is being developed specifically for children in sub-Saharan Africa who are most at risk of malaria.”
Advertisement
Malaria death toll
RTS,S is a frontrunner in the race to develop the first vaccine for malaria, which according to WHO figures for 2010 — the latest estimates available — infected around 220 million people, killing 660,000 of them. The toll is highest among small children in Africa.
The new data presented in Durban showed far less protection for infants, as opposed to young children, and also pointed to declining effectiveness over time.
At the one-year mark, efficacy among the young children group was 47 per cent against clinical malaria and 56 perc ent against severe malaria.
Among the infants group, it was 46-percent effective against clinical malaria and 36-percent effective against severe malaria at the one-year stage.
But at the 18-month mark, effectiveness had fallen to 46 per cent and 36 per cent among young children and to 27 per cent and 15 per cent among infants.
“There are a number of possible hypotheses for these differences we are looking at,” said Lucas Otieno, one of the principal investigators in the trial who works for the Kenya Medical Research Institute.
The theories include possible interference with the vaccine by maternal antibodies and the impact of vaccines for other diseases that were administered to the infants at around the same time, he said.
Otieno stressed that the trial “is ongoing”.
“We hope to have more information on the long-term protection some time in 2014. In addition, we will also be evaluating the impact of a booster dose given at 18 months after the primary vaccination series.” The initial series comprised three shots.
If you mean that the population is controlled by allowing malaria to kill thousands of people each year, yes it is.
If you mean a vaccine is going to control the population then I suggest you get back into your faraday cage as the radio signals are getting into your head again.
Heard an alarming statistic on the tv show QI that half the people who have been killed in the world have been killed by malaria. Not sure how they can say this with certainty from the times before records began but they claim its true. I think we underestimate this disease and anything that can help in the battle against has to be a good thing surely ?
Catherine,
We underestimate Malaria because it has been eradicated in most parts of Europe, so we don’t see sufferers. Also when a victim here has a repeat attack they’re normally in with medical care pretty quick and receive proper treatment. Africa, Asia and South America this is not always the case.
There has been protection definitely since the 50s daily dose of Paludrin tablets, tasted awful.
Lorelei are you saying that the vaccination is not necessary ? Is it just access to already developed medications that is the problem in developing countries?
God no.
Paludrin has to be taken daily whereas a vaccination lasts much longer.
Paludrin tastes vile son”clever” little so and sos (yours truly) will hide it under tongue and spit out.
The point on medical care is that anyone having a repeat attack (Malaria does not go away and at present there is no cure to get rid of the illness), are under treatment quickly and therefor saved.
I was a clever so and so in 1956 have had malaria since, had 2 repeat attacks don’t want no more.
The medical profession is getting closer and closer to a cure.
@Lorelei. Eradicated Malaria from Europe? The mosquitoes which spread the pathogen cannot survive in most European climates, they favor hot tropical regions hence why equatorial regions are malaria hot spots!
John,
Malaria existed in Cork back in the 1700s. The Anopheles mosquito (the only carrier of Malaria which is caused by a pregnant female biting the victim to feed, she the injects a de-coagulant to enable easier blood flow for her to feed which carries the malaria virus) is found in parts of southern Italy, France, Russia and Norway in Summer.
There are programmes which control the mosquito and kills them off eg smoke generators, sprays these are however expensive and beyond the reach of many countries eg China carrie out such action in those provinces where malaria is a threat the same programme would cost Tanzania more than 1/5th of annual budget.
John, malaria given the right conditions could reappear here. Is however unlikely due to our climate conditions.
Malaria was endemic in the USA right up to and beyond the Canadian border until it was successfully eradicated by spraying with insecticide. The malaria map is rapidly shrinking. In 1900, endemic malaria was present in almost every country. Nowadays, the disease has been eliminated in 111 countries and 34 countries are advancing towards elimination
Probably true, Sexy; but allowing millions of people to be killed by malaria is not the answer. We need contraception and education first and foremost.
There is a better way to control this than vaccines which only gives partial protection. With nano engineering they have now found a way to turn on and off certain genes and controls in the midge’s that stop reproduction. They release loads of males adolescence into the surrounding areas and within days and weeks the population of the midge’s was drastically reduced. They are also using the nano technology to engineer vaccines that do not require a dead virus’s. They engineer an exact replica of the virus on the outside but with none of the actual virus inside it. The body see’s the outer shell as a virus and attacks it and defends in the same way as a real virus. This means that when a new virus is detected they can engineer a safe vaccine within a really short period of time, and if the virus mutates they are only one step behind it.
The world would be a healthier place if Rachel Carson and her ‘Silent Spring’ fantasy had been consigned to the dustbin. Her legacy to the world is poverty and millions of deaths, the ultimate goal of hard core ‘environmentalists’
Truthfully, i was tested HIV + positive last 3years. I keep on managing the drugs i usually purchase from the health care agency to keep me healthy and strenghtful, i tried all i can too make this disease leave me alone, but unfortunately, it keep on eating up my life, this is what i caused myself, for allowing my fiance have sex with me insecurely without protection. Although i never knew he is HIV positive.
So last few 4days i came in contact with a lively article on the internet on how this Powerful Herb Healer get her well and healed. So as a patient i knew this will took my life one day, and i need to live with other friends and relatives too. So i copied out the Dr Koboko Yya the traditional healer’s email id: dr.koboko(at)gmail.com and I mailed him immediately, in a little while he mail me back that i was welcome to his temple home were by all what i seek for are granted. I was please at that time. And i continue with him, he took some few details from me and told me that he shall get back to me as soon as he is through with my work.
I was very happy as heard that from him. So Yesterday, as i was just coming from my friends house, Dr koboko Yya called me to go for checkup in the hospital and see his marvelous work that it is now HIV negative, i was very glad to hear that from him, so i quickly rush down to the nearest hospital to found out, only to hear from my hospital doctor called Browning Lewis that i am now HIV NEGATIVE. I jump up at him with the test note, he ask me how does it happen and i recede to him all i went through with Dr Koboko Yya I am now glad, so i am a gentle type of person that need to share this testimonies to everyone who seek for healing, because once you get calm and quiet, so the disease get to finish your life off.
So i will advice you contact him today for your healing at the above details: Email ID: dr.koboko(at)gmail.com CONTACT HIM NOW TO SAVE YOUR LIFE: dr.koboko(at)gmail.com AS HE IS SO POWERFUL AND HELPFUL TO ALL THAT HAVE THIS SICKNESS… http://www.drkobokospiritualtemple.simplesite.com
Good-day every one, my name is Mike Clinton, i want to share my experience with the general public on how i got my hiv aids cured, i have been reading so-many post of some people who were cured of hiv, but i never believed them, but one day bi wanted to tests the faith of the DR OGBOLE, then i contacted him on his email on DROGBOLETEMPLEOFCURE@GMAIL.COM, when i contact him, he told me so many things about my life and so many thing about me which was 100% correct, then i pleaded with him to help me out, then to my greatest surprise he prepared some medicine and he asked me to take it, which i did exactly the way the asked me to take them, he told me that in three days time tat i should go and check on my hiv status, i was kind of been surprise, when i went to the hospital to check of my status, the doctor was so surprise when he saw that i was hiv negative, i did not know how i am going to thank DR OGBOLE for his good work so i decided to share with the general public on what the great DR did for me, i am so thankful to GOD, for sending DR OGBOLE to my rescue, of you are out there having same illness you can contact him so he can help you out on DROGBOLETEMPLEOFCURE@GMAIL.COM, i live in united kingdom, you can also call me if you wish on +447031948646, thanks for sharing from my experience…………………….
Body of man (70s) discovered in Cork apartment as gardaí launch investigation
17 mins ago
858
Healthcare
Health unions suspend planned 'work-to-rule' following talks with the HSE
Updated
26 mins ago
4.5k
social welfare changes
If you lose your job and have worked for 5 years you'll get up to €450 a week under new rules
17 hrs ago
44.3k
80
Your Cookies. Your Choice.
Cookies help provide our news service while also enabling the advertising needed to fund this work.
We categorise cookies as Necessary, Performance (used to analyse the site performance) and Targeting (used to target advertising which helps us keep this service free).
We and our 161 partners store and access personal data, like browsing data or unique identifiers, on your device. Selecting Accept All enables tracking technologies to support the purposes shown under we and our partners process data to provide. If trackers are disabled, some content and ads you see may not be as relevant to you. You can resurface this menu to change your choices or withdraw consent at any time by clicking the Cookie Preferences link on the bottom of the webpage .Your choices will have effect within our Website. For more details, refer to our Privacy Policy.
We and our vendors process data for the following purposes:
Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a device. Personalised advertising and content, advertising and content measurement, audience research and services development.
Cookies Preference Centre
We process your data to deliver content or advertisements and measure the delivery of such content or advertisements to extract insights about our website. We share this information with our partners on the basis of consent. You may exercise your right to consent, based on a specific purpose below or at a partner level in the link under each purpose. Some vendors may process your data based on their legitimate interests, which does not require your consent. You cannot object to tracking technologies placed to ensure security, prevent fraud, fix errors, or deliver and present advertising and content, and precise geolocation data and active scanning of device characteristics for identification may be used to support this purpose. This exception does not apply to targeted advertising. These choices will be signaled to our vendors participating in the Transparency and Consent Framework.
Manage Consent Preferences
Necessary Cookies
Always Active
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then these services may not function properly.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not be able to monitor our performance.
Store and/or access information on a device 110 partners can use this purpose
Cookies, device or similar online identifiers (e.g. login-based identifiers, randomly assigned identifiers, network based identifiers) together with other information (e.g. browser type and information, language, screen size, supported technologies etc.) can be stored or read on your device to recognise it each time it connects to an app or to a website, for one or several of the purposes presented here.
Personalised advertising and content, advertising and content measurement, audience research and services development 143 partners can use this purpose
Use limited data to select advertising 113 partners can use this purpose
Advertising presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type or which content you are (or have been) interacting with (for example, to limit the number of times an ad is presented to you).
Create profiles for personalised advertising 83 partners can use this purpose
Information about your activity on this service (such as forms you submit, content you look at) can be stored and combined with other information about you (for example, information from your previous activity on this service and other websites or apps) or similar users. This is then used to build or improve a profile about you (that might include possible interests and personal aspects). Your profile can be used (also later) to present advertising that appears more relevant based on your possible interests by this and other entities.
Use profiles to select personalised advertising 83 partners can use this purpose
Advertising presented to you on this service can be based on your advertising profiles, which can reflect your activity on this service or other websites or apps (like the forms you submit, content you look at), possible interests and personal aspects.
Create profiles to personalise content 39 partners can use this purpose
Information about your activity on this service (for instance, forms you submit, non-advertising content you look at) can be stored and combined with other information about you (such as your previous activity on this service or other websites or apps) or similar users. This is then used to build or improve a profile about you (which might for example include possible interests and personal aspects). Your profile can be used (also later) to present content that appears more relevant based on your possible interests, such as by adapting the order in which content is shown to you, so that it is even easier for you to find content that matches your interests.
Use profiles to select personalised content 35 partners can use this purpose
Content presented to you on this service can be based on your content personalisation profiles, which can reflect your activity on this or other services (for instance, the forms you submit, content you look at), possible interests and personal aspects. This can for example be used to adapt the order in which content is shown to you, so that it is even easier for you to find (non-advertising) content that matches your interests.
Measure advertising performance 134 partners can use this purpose
Information regarding which advertising is presented to you and how you interact with it can be used to determine how well an advert has worked for you or other users and whether the goals of the advertising were reached. For instance, whether you saw an ad, whether you clicked on it, whether it led you to buy a product or visit a website, etc. This is very helpful to understand the relevance of advertising campaigns.
Measure content performance 61 partners can use this purpose
Information regarding which content is presented to you and how you interact with it can be used to determine whether the (non-advertising) content e.g. reached its intended audience and matched your interests. For instance, whether you read an article, watch a video, listen to a podcast or look at a product description, how long you spent on this service and the web pages you visit etc. This is very helpful to understand the relevance of (non-advertising) content that is shown to you.
Understand audiences through statistics or combinations of data from different sources 74 partners can use this purpose
Reports can be generated based on the combination of data sets (like user profiles, statistics, market research, analytics data) regarding your interactions and those of other users with advertising or (non-advertising) content to identify common characteristics (for instance, to determine which target audiences are more receptive to an ad campaign or to certain contents).
Develop and improve services 83 partners can use this purpose
Information about your activity on this service, such as your interaction with ads or content, can be very helpful to improve products and services and to build new products and services based on user interactions, the type of audience, etc. This specific purpose does not include the development or improvement of user profiles and identifiers.
Use limited data to select content 37 partners can use this purpose
Content presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type, or which content you are (or have been) interacting with (for example, to limit the number of times a video or an article is presented to you).
Use precise geolocation data 46 partners can use this special feature
With your acceptance, your precise location (within a radius of less than 500 metres) may be used in support of the purposes explained in this notice.
Actively scan device characteristics for identification 27 partners can use this special feature
With your acceptance, certain characteristics specific to your device might be requested and used to distinguish it from other devices (such as the installed fonts or plugins, the resolution of your screen) in support of the purposes explained in this notice.
Ensure security, prevent and detect fraud, and fix errors 92 partners can use this special purpose
Always Active
Your data can be used to monitor for and prevent unusual and possibly fraudulent activity (for example, regarding advertising, ad clicks by bots), and ensure systems and processes work properly and securely. It can also be used to correct any problems you, the publisher or the advertiser may encounter in the delivery of content and ads and in your interaction with them.
Deliver and present advertising and content 99 partners can use this special purpose
Always Active
Certain information (like an IP address or device capabilities) is used to ensure the technical compatibility of the content or advertising, and to facilitate the transmission of the content or ad to your device.
Match and combine data from other data sources 72 partners can use this feature
Always Active
Information about your activity on this service may be matched and combined with other information relating to you and originating from various sources (for instance your activity on a separate online service, your use of a loyalty card in-store, or your answers to a survey), in support of the purposes explained in this notice.
Link different devices 53 partners can use this feature
Always Active
In support of the purposes explained in this notice, your device might be considered as likely linked to other devices that belong to you or your household (for instance because you are logged in to the same service on both your phone and your computer, or because you may use the same Internet connection on both devices).
Identify devices based on information transmitted automatically 88 partners can use this feature
Always Active
Your device might be distinguished from other devices based on information it automatically sends when accessing the Internet (for instance, the IP address of your Internet connection or the type of browser you are using) in support of the purposes exposed in this notice.
Save and communicate privacy choices 69 partners can use this special purpose
Always Active
The choices you make regarding the purposes and entities listed in this notice are saved and made available to those entities in the form of digital signals (such as a string of characters). This is necessary in order to enable both this service and those entities to respect such choices.
have your say